Addex Therapeutics
ADXN
Addex Therapeutics (ADXN) news
Recent news
Addex Therapeutics announces executive management changes
Addex Therapeutics has announced a series of executive management changes, effective immediately. Dr. Thomas Hargrave has been appointed as Chief Financial Officer, succeeding Dr. Emily Langford, who has decided to step down to pursue other professional opportunities. Dr. Hargrave brings over 15…
AInvest Wire · Oct 2, 2026Addex Therapeutics Q2 net income CHF -1.745 million
AInvest Wire · Sep 28, 2026Addex Therapeutics: Addex raises USD 2.8M through ATM pact, extends cash runway to 4Q 2027
AInvest Wire · Aug 26, 2026Light Horse does not author, endorse or verify the headlines, and their appearance here is not an endorsement of any view they express.
This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.